TIAA CREF Trust’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

TIAA CREF Trust’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-29,632	Closed	-$536K	–	350
2015 Q1	$536K	Hold	29,632	–	–	0.01%	280
2014 Q4	$699K	Hold	29,632	–	–	0.01%	269
2014 Q3	$717K	Hold	29,632	–	–	0.01%	252
2014 Q2	$833K	Buy	29,632 +3,484	+13%	+$105K	0.01%	244
2014 Q1	$889K	Buy	26,148 +14,600	+126%	+$499K	0.01%	227
2013 Q4	$221K	Buy	+11,548	New	+$210K	﹤0.01%	294

Other funds holding CTIC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

TIAA CREF Trust's CTIC Position: Q2 2015 in Review

TIAA CREF Trust sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2015, closing a stake of 29,632 shares — an estimated $536K sold.

TIAA CREF Trust first reported a position in CTIC in Q4 2013 and held it in 6 quarters. The position peaked at $889K in Q1 2014. 95 funds tracked by Wall St. Rank hold CTIC as of Q2 2015.

TIAA CREF Trust reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2015 after selling out during the quarter.
TIAA CREF Trust sold 29,632 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2015, an estimated $536K.
TIAA CREF Trust first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2013 and held it in 6 quarters.
TIAA CREF Trust's CTI BioPharma Corp. (DE) Common Stock position peaked at $889K in Q1 2014.
95 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2015.

Based on TIAA CREF Trust's 13F filing for Q2 2015, filed 28 Jul 2015.